Multiple Sclerosis: all 3,524 studies
Page 29 of 36. Open to participants first (668), then studies with results posted, then the rest; newest registration first within each.
- Measuring Active Microglia in Progressive Multiple SclerosisCompletedNCT02207075
- Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADACompletedNCT02205489Phase 4
- A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy AdultsCompletedNCT02201849Phase 1
- A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple SclerosisStatus unknownNCT02200718Phase 1
- Mobility Enhancing Nursing InterventionCompletedNCT02198599Not applicable
- Neuropsychological Profile of a Patient's Group With Multiple Sclerosis and Effect of a Cognitive Rehabilitation ProgramStatus unknownNCT02193906Not applicable
- A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303CompletedNCT02193217Phase 1
- Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple SclerosisCompletedNCT02166021Phase 2
- Real-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)CompletedNCT02159573
- Outcomes Data of Adipose Stem Cells to Treat Multiple SclerosisStatus unknownNCT02157064
- A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple SclerosisStatus unknownNCT02149706Phase 2
- Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS PatientsCompletedNCT02146534Phase 4
- Resistance Training and Amino Pyridine in Multiple SclerosisCompletedNCT02143167Phase 4
- Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis PatientsCompletedNCT02142764Not applicable
- Safety and Efficacy of Natalizumab (BG00002, Tysabri®) in Russian Participants With Relapsing Remitting Multiple Sclerosis (RRMS)CompletedNCT02142205Phase 4
- Natalizumab Subcutaneous Immunogenicity and Safety StudyTerminatedNCT02142192Phase 2
- Computerized Cognitive Exercise Training Treatment for Adults With Multiple SclerosisStatus unknownNCT02141386Not applicable
- Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With GilenyaCompletedNCT02141022Not applicable
- Sphingosine-1 Phosphate -Receptor Targeting and Microglial ActivationCompletedNCT02139696
- Biologic Basis for Multiple Sclerosis Disease Progression in RRMS Patients Treated With GilenyaCompletedNCT02137707
- Safety and Efficacy in Pediatric MS Patients Prescribed TysabriCompletedNCT02137109
- Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness StudyCompletedNCT02137044Not applicable
- Mindfulness-based Stress Reduction in Multiple SclerosisCompletedNCT02136485Not applicable
- Stabilometric Assessment of Balance Recovery in Persons With Multiple SclerosisCompletedNCT02131285Not applicable
- Treating Foot Drop in People With Multiple Sclerosis Using Electrical StimulationCompletedNCT02123537Not applicable
- BAY86-5046 (Betaseron), Non Interventional StudiesCompletedNCT02121444
- Allocentric Memory in MS and Resting State Functional MRICompletedNCT02118298
- EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis PatientsCompletedNCT02117375Not applicable
- Study of Exercise on Impact of Cognitive Functioning in Multiple Sclerosis PatientsStatus unknownNCT02106052Not applicable
- Protective Role of Oxcarbazepine in Multiple SclerosisCompletedNCT02104661Phase 2
- Effects of a 12-week Respiratory Muscles Training Program in Persons With Relapsing- Remitting Multiple SclerosisStatus unknownNCT02104492Not applicable
- Implementing Physical Activity Guidelines for Adults With MSCompletedNCT02100020Not applicable
- Adherence to Treatment With Tecfidera™ in Multiple Sclerosis PatientsCompletedNCT02099370
- Vitamin D3 and the Stress-axis in MSTerminatedNCT02096133Phase 2
- Study to Evaluate Fatigue in Participants With Relapsing Remitting Multiple Sclerosis When Treated With Dimethyl FumarateWithdrawnNCT02090348Phase 4
- Safety and Tolerability of Quetiapine in Multiple SclerosisCompletedNCT02087631Phase 1/2
- Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)No longer availableNCT02084121
- Multidimensional Assessment of Fatigue in Multiple Sclerosis- Observational Study - TicinoCompletedNCT02082002
- Consolidation & Interference in Multiple SclerosisCompletedNCT02081508Not applicable
- Tolerability and Quality of Life Study in Participants Who Switched to Avonex PenCompletedNCT02076841
- An Observational Post-Marketing Safety Registry of Sativex®CompletedNCT02073474
- Effects of a Home Based Walking Program Using Rhythmic Auditory Stimulation in Patients With Multiple SclerosisCompletedNCT02065284Not applicable
- Analgesic Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) for Central Neuropathic Pain in Multiple SclerosisStatus unknownNCT02059096Phase 3
- A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple SclerosisStatus unknownNCT02057159Phase 2/3
- Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) PatientsTerminatedNCT02048358Phase 1
- Upper Limbs Intervention in Multiple SclerosisCompletedNCT02047825Not applicable
- Neuroretinal Biomarkers in Neurodegenerative DiseasesCompletedNCT02047760
- Dimethyl Fumarate (DMF) Observational StudyCompletedNCT02047097
- A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese VolunteersCompletedNCT02046629Phase 1
- Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis CriterionCompletedNCT02043964Not applicable
- Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple SclerosisCompletedNCT02035514Phase 1/2
- Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple SclerosisCompletedNCT02034188Phase 1/2
- Testing the Efficacy of Self-Generation Treatment ProtocolStatus unknownNCT02032589Not applicable
- Impact of CRISP on Self-Efficacy, Loneliness, and DepressionCompletedNCT02030197Not applicable
- Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple SclerosisCompletedNCT02021162
- Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 MonthsCompletedNCT02017808
- Comparison of the Efficacy and Mechanisms for MBCT and CT for Multiple Sclerosis (MS) Chronic PainCompletedNCT02012439Phase 1/2
- Safety and Brain Protection Effects of the Green Tea Extract Theaphenon 95% (95% Pure EGCG) in Multiple SclerosisWithdrawnNCT02011451Phase 2
- Study of Electrical Impedance Myography (EIM) in ALSCompletedNCT02011204
- Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MSCompletedNCT02010554Not applicable
- Effects of the Cross-Training in Patients With Multiple SclerosisCompletedNCT02010398Not applicable
- Evaluation of Nutritional Status and Fatigue in Patients With Multiple SclerosisCompletedNCT02008669
- Exercise in Multiple Sclerosis: Effects on Cognitive Function and Brain ConnectivityCompletedNCT02005237Not applicable
- JC Virus Reactivation in Multiple SclerosisCompletedNCT02004444
- Correlation Between Relapses in Multiple Sclerosis (MS) and Vitamin D IntakeCompletedNCT01994018
- FlexToBa for People With Multiple SclerosisCompletedNCT01993095Not applicable
- Immune Regulation in Multiple Sclerosis: The Effect of Glatiramer Acetate on MicroRNA Expression in Antigen-Presenting CellsCompletedNCT01993004
- Body Weight Supported Treadmill Training in Persons With Multiple SclerosisCompletedNCT01992679Phase 1/2
- Study to Compare the Clinical and Radiological Efficacy of 625 mg Versus 1250 mg of Oral Methylprednisolone in Patients With Multiple Sclerosis in RelapseCompletedNCT01986998Phase 4
- Difference in Efficacy of Natalizumab Versus Fingolimod for the Treatment of Multiple SclerosisCompletedNCT01981161
- Detecting and Addressing Preclinical DisabilityCompletedNCT01979081
- Intellectual Enrichment to Build Cognitive Reserve in MSCompletedNCT01978574Not applicable
- Walking With FES or AFO in People With MS With Foot DropCompletedNCT01977287
- A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ß-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)WithdrawnNCT01975298Phase 3
- High-Field MRI Iron-Based Contrast-Enhanced Characterization of Multiple Sclerosis and Demyelinating DiseasesWithdrawnNCT01973517
- Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis PatientsCompletedNCT01968902Phase 4
- Fall Risk Reduction in Multiple Sclerosis: Exercise Versus BehaviorCompletedNCT01956227Phase 1/2
- Establishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative DiseasesWithdrawnNCT01954875
- Use of an Electronic Diary by People With Multiple SclerosisStatus unknownNCT01954823Not applicable
- Effect of Vitamin D Replacement on Immune Function and Cognition in MS PatientsCompletedNCT01952483
- T and B Cell Responses in Autoimmune DiseasesTerminatedNCT01947036
- Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover DesignCompletedNCT01945359
- Ireland Natalizumab (TYSABRI) Observational ProgramCompletedNCT01943526
- Safety and Efficacy of Fingolimod in MS Patients in ChinaWithdrawnNCT01941004Phase 3
- Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple SclerosisCompletedNCT01933802Phase 1
- Repeat Infusion of Autologous Bone Marrow Cells in Multiple SclerosisCompletedNCT01932593Not applicable
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- A Study Evaluating the Effectiveness of Tecfidera (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported OutcomesCompletedNCT01930708Phase 4
- Development of a Motivational Intervention to Improve Treatment Adherence in MSCompletedNCT01925690Not applicable
- Effect of I-TRAVLE Training on Arm Function in MS and Chronic Stroke PatientsStatus unknownNCT01918748Not applicable
- Testing Mitochondria Activity and Blood Lipid Content of Multiple Sclerosis PatientsStatus unknownNCT01918501Not applicable
- A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple SclerosisCompletedNCT01917019Phase 3
- Wahls Paleo Diet and Progressive Multiple SclerosisCompletedNCT01915433Not applicable
- Functional Electrical Stimulation for People With Multiple Sclerosis Who Experience Foot DropCompletedNCT01914016Not applicable
- Biogen Multiple Sclerosis Pregnancy Exposure RegistryCompletedNCT01911767
- MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation TrialCompletedNCT01910259Phase 2
- Comprehensive Analysis of Relapse in Multiple SclerosisStatus unknownNCT01906684Not applicable
- Adherence Trial With MS LifeLines ® ServicesTerminatedNCT01905527
- Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMSCompletedNCT01903291
- Evaluation of the Response to Acthar Gel Therapy in Patients Who Failed Intravenous Methylprednisolone (IVMP) for MS RelapsesStatus unknownNCT01900093Not applicable